- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/50 - Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
Patent holdings for IPC class A61K 38/50
Total number of patents in this class: 597
10-year publication summary
|
47
|
53
|
37
|
56
|
68
|
63
|
67
|
81
|
50
|
17
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Theriva Biologics, Inc. | 81 |
42 |
| Erytech Pharma | 75 |
17 |
| President and Fellows of Harvard College | 5792 |
16 |
| Polaris Group | 16 |
13 |
| Icahn School of Medicine at Mount Sinai | 859 |
12 |
| Jazz Pharmaceuticals Ireland Limited | 121 |
11 |
| University of Massachusetts | 2130 |
11 |
| Beam Therapeutics Inc. | 176 |
10 |
| The Regents of the University of California | 18943 |
9 |
| California Institute of Technology | 3884 |
8 |
| The Trustees of the University of Pennsylvania | 4122 |
8 |
| AERase, Inc. | 18 |
8 |
| Synthetic Biologics, Inc. | 35 |
8 |
| Dana-Farber Cancer Institute, Inc. | 2455 |
7 |
| The Rockefeller University | 562 |
7 |
| Thornhill Therapeutics, Inc. | 21 |
7 |
| Rowan University | 144 |
6 |
| The Trustees of Indiana University | 630 |
6 |
| AbbVie Biotechnology Ltd. | 185 |
5 |
| University of Florida Research Foundation, Inc. | 3883 |
5 |
| Other owners | 381 |